Iceland· IS-EU/1/03/268/001-004
Cholestagel
A colesevelam product containing colesevelamum inn hýdróklóríð, registered in Iceland by CHEPLAPHARM Arzneimittel GmbH. The same ATC class is registered in 14 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Colesevelam is registered in 14 of 19 countries.
Countries holding a registration under ATC C10AC04 (colesevelam), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 8 of them publish a price we can compare per daily dose
Colesevelam · ATC C10AC04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of colesevelam costs, country by country.
Normalised to the WHO defined daily dose (3.75 g), the median price runs from $1.57 in United States to $5.96 in Spain — a ×3.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Colesevelam · price per daily dose (3.75 g)
USD · FX 28 Sept 2026
- ES Spain$5.96
- US United States$1.57 (acquisition cost)
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Colesevelamum INN hýdróklóríð
- Manufacturer
- CHEPLAPHARM Arzneimittel GmbH
- Country
- Iceland (IS)
- ATC code
- C10AC04
- ATC class
- Colesevelam
- Defined daily dose
- 3.75 g, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean972457180 stk x1 pakkiISK 43480
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
63 interactions on record for colesevelam.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Colesevelam · interactions on record
63 records
- 5 severe
- 58 moderate
Most severe, free to view
- BexaroteneL01XF03severe
- BexarotenL01XX25severe
- Mycophenolic acidL04AA06severe
- TeriflunomidL04AA31severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Colesevelam in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/da007ae6-a18b-47e5-b373-f0b6d98f1ce0 GET /v1/drugs/da007ae6-a18b-47e5-b373-f0b6d98f1ce0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "C10AC04",
"marketed": false,
"strength": "625 mg",
"ma_number": "EU/1/03/268/001-004",
"substance": "Colesevelamum INN hýdróklóríð",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "38082"
}See everything about colesevelam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.